Total Payments
$8,782
2024 Payments
$3,991
Companies
31
Transactions
385
Medicare Patients
1,063
Medicare Billing
$123,232

Payment Breakdown by Category

Food & Beverage$8,205 (93.4%)
Education$432.79 (4.9%)
Travel$144.28 (1.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $8,205 376 93.4%
Education $432.79 8 4.9%
Travel and Lodging $144.28 1 1.6%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $1,495 60 $0 (2024)
GlaxoSmithKline, LLC. $1,300 65 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $859.01 38 $0 (2024)
GENZYME CORPORATION $851.65 37 $0 (2024)
Actelion Pharmaceuticals US, Inc. $629.42 24 $0 (2024)
Regeneron Healthcare Solutions, Inc. $549.16 22 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $408.07 19 $0 (2024)
Grifols USA, LLC $308.84 16 $0 (2024)
Insmed, Inc. $234.57 13 $0 (2024)
Janssen Pharmaceuticals, Inc $206.13 13 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $3,991 172 AstraZeneca Pharmaceuticals LP ($802.50)
2023 $3,590 158 GlaxoSmithKline, LLC. ($694.96)
2022 $986.24 46 GENZYME CORPORATION ($179.69)
2021 $87.34 4 Boehringer Ingelheim Pharmaceuticals, Inc. ($41.00)
2020 $127.60 5 Advanced Respiratory, Inc ($68.68)

All Payment Transactions

385 individual payment records from CMS Open Payments — Page 1 of 16

Date Company Product Nature Form Amount Type
12/26/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $17.55 General
Category: RESPIRATORY
12/20/2024 Regeneron Healthcare Solutions, Inc. Food and Beverage In-kind items and services $120.83 General
12/19/2024 Takeda Pharmaceuticals U.S.A., Inc. GLASSIA (Biological) Food and Beverage In-kind items and services $30.60 General
Category: IMMUNOLOGY
12/16/2024 Grifols USA, LLC Prolastin-C Liquid (Biological) Food and Beverage In-kind items and services $21.97 General
Category: Pulmonology
12/16/2024 Grifols USA, LLC Prolastin-C Liquid (Biological) Food and Beverage In-kind items and services $13.33 General
Category: Pulmonology
12/12/2024 Actelion Pharmaceuticals US, Inc. OPSUMIT (Drug), UPTRAVI Food and Beverage In-kind items and services $21.08 General
Category: Cardiology
12/11/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $126.42 General
Category: Immunology
12/10/2024 Amgen Inc. TEZSPIRE (Biological) Food and Beverage In-kind items and services $22.86 General
Category: Inflammation
12/09/2024 Merck Sharp & Dohme LLC ZERBAXA (Drug) Food and Beverage In-kind items and services $19.00 General
Category: INFECTIOUS DISEASE
12/06/2024 Philips North America LLC (AK6) Vest Therapy (Device) Food and Beverage Cash or cash equivalent $16.13 General
Category: Medical Device
12/05/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $17.65 General
Category: Immunology
11/26/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $17.86 General
Category: INFLAMMATION AND IMMUNOLOGY
11/14/2024 AstraZeneca Pharmaceuticals LP TEZSPIRE (Biological) Food and Beverage In-kind items and services $21.75 General
Category: Respiratory
11/14/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $14.37 General
Category: Respiratory
11/13/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $14.43 General
11/12/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $24.94 General
Category: Cardiology/Vascular Diseases
11/08/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $15.67 General
11/07/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $15.90 General
Category: Immunology
11/07/2024 Insmed, Inc. Arikayce (Drug) Food and Beverage In-kind items and services $10.48 General
Category: Respiratory
11/06/2024 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Food and Beverage In-kind items and services $28.52 General
Category: RESPIRATORY
11/05/2024 Takeda Pharmaceuticals U.S.A., Inc. GLASSIA (Biological) Food and Beverage In-kind items and services $30.49 General
Category: IMMUNOLOGY
10/31/2024 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $18.54 General
Category: Respiratory
10/30/2024 GlaxoSmithKline, LLC. Food and Beverage In-kind items and services $117.90 General
10/30/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Education In-kind items and services $23.32 General
Category: Respiratory
10/30/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Education In-kind items and services $21.72 General
Category: Respiratory

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 14 893 1,349 $241,242 $97,516
2022 8 170 316 $64,790 $25,716
Total Patients
1,063
Total Services
1,665
Medicare Billing
$123,232
Procedure Codes
22

All Medicare Procedures & Services

22 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 137 337 $36,733 $19,098 52.0%
99291 Critical care, first 30-74 minutes Facility 2023 50 116 $53,476 $17,446 32.6%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 67 187 $52,460 $16,488 31.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 125 177 $31,571 $15,394 48.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 68 68 $16,932 $7,569 44.7%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 55 57 $17,499 $6,852 39.2%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 52 54 $8,802 $4,599 52.2%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 27 30 $6,900 $3,985 57.8%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 39 39 $8,112 $3,678 45.3%
94726 Test to determine lung volumes using sensors Facility 2023 79 79 $2,291 $708.63 30.9%
94060 Test to measure expiratory airflow and volume changes before and after medication administration Facility 2023 84 85 $3,230 $651.10 20.2%
94729 Test to examine how well the lungs exchange gases Facility 2023 81 81 $1,782 $536.22 30.1%
95012 Test to measure the level of nitric oxide gas Office 2023 18 22 $1,012 $282.24 27.9%
99406 Smoking and tobacco use intensive counseling, 4-10 minutes Office 2023 11 17 $442.00 $230.69 52.2%
99291 Critical care, first 30-74 minutes Facility 2022 28 72 $33,192 $11,660 35.1%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 57 145 $15,805 $7,563 47.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 23 23 $5,727 $2,849 49.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 14 20 $3,260 $1,907 58.5%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 11 19 $5,700 $1,445 25.4%
94726 Test to determine lung volumes using sensors Facility 2022 12 12 $348.00 $109.56 31.5%
94060 Test to measure expiratory airflow and volume changes before and after medication administration Facility 2022 13 13 $494.00 $101.40 20.5%
94729 Test to examine how well the lungs exchange gases Facility 2022 12 12 $264.00 $80.88 30.6%

About Ryan Logue

Ryan Logue is a Student in an Organized Health Care Education/Training Program healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/01/2016. The National Provider Identifier (NPI) number assigned to this provider is 1093178477.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ryan Logue has received a total of $8,782 in payments from pharmaceutical and medical device companies, with $3,991 received in 2024. These payments were reported across 385 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($8,205).

As a Medicare-enrolled provider, Logue has provided services to 1,063 Medicare beneficiaries, totaling 1,665 services with total Medicare billing of $123,232. Data is available for 2 years (2022–2023), covering 22 distinct procedure/service records.

Practice Information

Products in Payments

  • DUPIXENT (Biological) $1,296
  • TEZSPIRE (Biological) $757.51
  • TRELEGY ELLIPTA (Drug) $621.35
  • OPSUMIT (Drug) $599.64
  • OFEV (Drug) $592.80
  • NUCALA (Biological) $560.53
  • GLASSIA (Biological) $400.84
  • Prolastin-C Liquid (Biological) $294.40
  • BREZTRI (Drug) $259.06
  • Arikayce (Drug) $234.57
  • FASENRA (Biological) $218.99
  • XARELTO (Drug) $206.13
  • NA (Device) $198.93
  • YUPELRI (Drug) $179.60
  • FLOWTRIEVER CATHETER, S (Device) $177.74
  • AIRSUPRA (Drug) $136.19
  • TYVASO (Drug) $130.62
  • STIOLTO RESPIMAT (Drug) $130.52
  • LOKELMA (Drug) $99.18
  • ACTHAR (Biological) $89.96

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Indianapolis